The WHO 2016 diagnosis was inferred from WHO grading (2/3 = Astrocytoma; 4 = GBM) and molecular features (IDH mutant, without 1p/19q co-deletion). This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).